Heparin in vitro sensitivity of the activated partial thromboplastin time in canine plasma depends on reagent

Journal of Veterinary Diagnostic Investigation

Volumn 15, Issue 6, 2003, Pages 588-591

  Mischke, Reinhard ^a  

^a UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA; CANIS FAMILIARIS;

EID: 0348234896     PISSN: 10406387     EISSN: None     Source Type: Journal    
DOI: 10.1177/104063870301500615     Document Type: Article

References (20)

1. Baker BA, Adelman MD, Smith PA, Osborne JC: 1997, Inability of the activated partial thromboplastin time to predict heparin levels. Time to assess guidelines for heparin assays. Arch Intern Med 157:2475-2479.
2. Basu D, Gallis A, Hirsh J: 1972, A prospective study of the value of monitoring heparin treatment with the activated partial thromboplastin time. N Engl J Med 287:324-327.
3. Brigden ML, Johnston M: 2000, A survey of APTT reporting in Canadian Medical Laboratories: the need for increased standardization. Am J Clin Pathol 114:276-282.
4. D'Angelo A, Seveso MP, D'Angelo SV, et al.: 1990, Effect of clot-detection methods and reagents on activated partial thromboplastin time (APTT). Implications in heparin monitoring by APTT. Am J Clin Pathol 94:297-306.
5. Gawoski JM, Arkin CF, Bovill T, et al.: 1987, The effects of heparin on the activated partial thromboplastin time of the College of American Pathologists survey specimens: responsiveness, precision, and sample effects. Arch Pathol Lab Med 111: 785-790.
6. Green RA: 1980, Activated partial thromboplastin time in monitoring heparinized dogs. Am J Vet Res 11:1793-1797.
7. Haushofer A, Halbmayer WM, Fischer M: 1997. Überwachung der Heparintherapie mit der aktivierten partiellen Thromboplastinzeit (APTT) - Voraussetzungen und klinische. Bedeutung. Ellipse 13:79-84.
8. Hellebrekers LJ, Slappendel RJ, Van den Brom WE: 1985, Effect of sodium heparin and antithrombin III concentration on activated partial thromboplastin time in the dog. Am J Vet Res 46:1460-1462.
9. Kitchen S, Preston FE: 1996, The therapeutic range for heparin therapy: relationship between six activated partial thromboplastin time reagents and two heparin assays. Thromb Haemostasis 75:734-797.
10. Mischke R: 2001, Optimization of coagulometric tests that incorporate human plasma for determination of coagulation factor activities in canine plasma. Am J Vet Res 62:625-629.
11. Mischke R, Jacobs C: 2001, The monitoring of heparin administration by screening tests in experimental dogs. Res Vet Sci 70:101-108.
12. Poller L, Thomson JM, Taberner DA: 1989, Use of the activated partial thromboplastin time for monitoring heparin therapy: problems and possible solutions. Ric Clin Lab 19:363-370.
13. Reed SV, Haddon ME, Denson KWE: 1994: An attempt to standardize the APTT for heparin monitoring, using the P.T. ISI/INR system of calibration. Results of a 13 centre study. Thromb Res 74:515-522.
14. Rosborough TK: 1997, Comparison of anti-factor Xa heparin activity and activated partial thromboplastin time in 2,773 plasma samples from unfractionated heparin-treated patients. Am J Clin Pathol 108:662-668.
15. Rosborough TK: 1998, Comparing different lots of activated partial thromboplastin time. Am J Clin Pathol 110:173-177.
16. Shapiro GA, Huntzinger SW, Wilson JE: 1977, Variation among commercial activated partial thromboplastin time reagents in response to heparin. Am J Clin Pathol 67:477-480.
17. Shojania AM, Tetreault J, Turnbull G: 1988, The variations between heparin sensitivity of different lots of activated partial thromboplastin time reagent produced by the same manufacturer. Am J Clin Pathol 89:19-23.
18. Van den Besselaar AM, Meeuwisse-Braun J, Bertina RM: 1990, Monitoring heparin therapy: relationships between the activated partial thromboplastin time and heparin assays based on ex-vivo heparin samples. Thromb Haemostasis 63:16-23.
19. Van der Velde EA, Poller L: 1995, The APTT monitoring of heparin - the ISTH/ICSH collaborative study. Thromb Haemostasis 73:73-81.
20. Zimmermann R, Springer S, Harenberg J, et al.: 1987, Laboratory control of heparin and thrombolytic therapy by thrombin clotting time and partial thromboplastin time. Ärztl Lab 33:121-126.